https://www.selleckchem.com/pr....oducts/Dihydroartemi
6-fold higher odds of poorer clinical outcome in mRS shift analysis (p = 0.01) compared to MT-only patients who had excellent 3-month clinical outcome (mRS 0-1) three times more often (p = 0.009). There were no significant differences between the groups in process times, mTICI, or number of hemorrhagic complications. A trend of less distal embolization and higher number of device passes was observed among the MT-only patients. MT without prior IVT was associated with an improved overall three-month clinical outcome in ac
Like
Comment
Share
